Skip to main content

Table 1 Anthropometric and metabolic data of the whole patient cohort and of patients taking only antihypertensive drugs

From: Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy

  Whole patient cohort Patients not taking antidiabetic and/or lipid lowering drugs
  All patients (n = 129) Males (n = 46) Females (n = 83) All patients (n = 104) Males (n = 30) Females (n = 74)
Age (yr) 51.95 ± 10.1 51.4 ± 9.6 52.3 ± 10.5 50.9 ± 10.1 49.4 ± 10.2 51.5 ± 10.1
Weight (kg) 95.8 ± 13.8 102.7 ± 12.3 91.9 ± 13.1** 94.4 ± 13.2 100.2 ± 11.9 92.0 ± 13.1*
Height (cm) 161.8 ± 9.4 171.6 ± 6.7 156.4 ± 5.5* 160.6 ± .8.5 1.7 ± .05 160 ± 5.7**
Systolic Arterial Pressure (mmHg) 130.0 (125–140) 130.0 (125–140) 130.0 (125–140) 130.0 (125–140) 132.0 (128.8–140.0) 130.0 (125–140)
Diaystolic Arterial Pressure (mmHg) 85.0 (75.0–90.0) 85.0 (80.0–91.3) 85.0 (75.0–90.0) 85.0 (75.0–90.0) 85.0 (80.0–91.3) 85.0 (75.0–90.0)
WC (cm) 112.8 ± 10.5 116.1 ± 9.3 110.9 ± 10.7* 111.8 ± 9.8 114.3 ± 8.3 110.7 ± 10.3
BMI (kg/m2) 35.5 (32.4–40.7) 33.7 (32.0–37.6) 36.7 (33.5–42.0)* 35.7 (32.4–40.6) 33.1 (31.8–36.8) 36.9 (33.5–41.5)*
VAI 1.9 (1.2–2.8) 2.1 (1.4–3.1) 1.8 (1.2–2.6) 1.8 (1.2–2.6) 2.0 (1.4–3.5) 1.8 (1.2–2.5)
TBW% 44.9 ± 5.6 50.6 ± 2.9 41.7 ± 3.9** 44.3 ± 5.4 50.8 ± 2.9 41.7 ± 3.8**
ECW% 43.0 ± 4.4 41.4 ± 4.1 43.9 ± 4.4** 43.1 ± 4.5 40.8 ± 3.7 44.1 ± 4.5**
FM% 39.8 ± 7.5 32.5 ± 4.3 43.8 ± 5.6** 40.3 ± 7.6 31.6 ± 4.6 43.8 ± 5.4**
MM% 42.3 ± 8.4 45.0 ± 8.6 40.8 ± 7.9 42.2 ± 8.2 46.2 ± 8.2 40.6 ± 7.6
Plasma Glusose (mg/dl) 98.0 (91.0–107.0) 101.0 (93.5–112.0) 96.0 (88.0–107.0) 96.5 (88.8–106.0) 99.0 (92.0–107.0) 95.0 (87.0–105.5)
Total Cholesterol (mg/dl) 201.0 ± 40.3 196.8 ± 44.1 203.3 ± 38.1 204.8 ± 38.9 210.3 ± 41.7 202.6 ± 37.9
HDL Cholesterol (mg/dl) 49.0 ± 11.4 41.7 ± 9.4 53.0 ± 10.5** 49.8 ± 11.5 41.5 ± 9.4 53.1 ± 10.6**
LDL Cholesterol (mg/dl) 134.2 ± 38.1 118.1 ± 34.8 143.6 ± 37.4 127.9 ± 36.1 133.1 ± 39.7 125.8 ± 34.6
Triglycerides (mg/dl) 131.0 (92.0–169.5) 143.0 (103.3–211.8) 118.0 (85.0–158.0)* 123.0 (88.3–168.8) 148.5 (102.3–227.5) 116.5 (82.5–154.3)*
Triglycerides/HDL ratio 2.7 (1.7–3.8) 3.5 (2.3–5.3) 2.3 (1.5–3.1)** 2.5 (1.6–3.5) 3.5 (2.3–5.8) 116.5 (82.5–154.3)**
SGOT 23.0 (18.0–29.5) 26.0 (21.8–36.0) 21.0 (17.0–25.0)** 23 (18–19) 28.0 (22.0–36.0) 21.0 (17.0–25.0)**
SGPT 28.0 (19.0–43.5) 43.0 (28.0–61.3) 22.0 (16.0–31.0)** 27 (18.5–41) 43.0 (28.0–61.0) 22.0 (16.8–31.0)**
  1. *p < 0.05 vs males
  2. **p < 0.01 vs males